Charles River Laboratories International, headquartered in Wilmington, Massachusetts, provides products and services to pharmaceutical and biotechnology companies with 20,000 employees. The company offers research models, safety assessment, and manufacturing solutions since its IPO in 2000.
CRL has been in the news recently: Charles River Laboratories International Inc (CRL) saw its stock rise on Wednesday due to better-than-expected first-quarter 2025 earnings results. Overall, U.S. stocks experienced an uptick, with the Dow Jones index increasing by approximately 200 points.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!